ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q3 2021 Results - Earnings Call Transcript

SA Transcripts
153.96K Followers

Q3: 2021-11-01 Earnings Summary

EPS of $1.01 beats by $0.31
 | Revenue of $52.06M (-1.73% Y/Y) beats by $2.36M

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q3 2021 Earnings Conference Call November 1, 2021 8:30 AM ET

Corporate Participants

Lisa Wilson - Investor Relations
Nikhil Lalwani - President and Chief Executive Officer
Steve Carey - Chief Financial Officer

Conference Call Participants

Elliot Wilbur - Raymond James
Brandon Folkes - Cantor Fitzgerald

Operator

Good day everyone, and welcome to today’s ANI Pharmaceuticals Third Quarter 2021 Earnings Results Call. At this time all participants are in a listen-only mode. [Operator Instructions] Please note, this call is being recorded.

It’s now my pleasure to turn the program over to Lisa Wilson.

Lisa Wilson

Thank you, Emma. Welcome to ANI Pharmaceuticals’ Q3 2021 earnings results call. This is Lisa Wilson, Investor Relations for ANI. With me on today’s call are Nikhil Lalwani, President and Chief Executive Officer; and Steve Carey, Chief Financial Officer of ANI. You can also access the webcast of this call through the Investors section of the ANI website at anipharmaceuticals.com.

Before we get started, I would like to remind everyone that any statements made on today’s conference call that express a belief, expectation, projection, forecast, anticipation or intent regarding future events and the company’s future performance may be considered forward-looking statements as defined by the Private Securities Litigation Reform Act. These forward-looking statements are based on information available to ANI Pharmaceuticals management as of today and involve risks and uncertainties, including those noted in our press release issued this morning and our filings with the SEC. Such forward-looking statements are not guarantees of future performance. Actual results may differ materially from those projected in the forward-looking statements. ANI specifically disclaims any intent or obligation to update these forward-looking statements except as required by law.

The archived webcast will be available for 30 days on our website anipharmaceuticals.com. For the benefit of those who

Recommended For You

About ANIP Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on ANIP